Insider trade

CEO sold ~$4.17M of SBRA shares in the open market

Traded Sep 8, 2026 · Filed Sep 9, 2026

Why it stands out

The CEO of Sabra Health Care REIT sold $4.17M of Sabra Health Care REIT shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEOIndirect holding$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$4,166,000

Shares × reported transaction price

Timing vs results

36 days after results of Aug 3, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−3.3%	+0.6%	−3.9%

Past results only. Not a forecast.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026.
The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.66 to $20.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.